Filter
181
Filtered Results: 181
Text search:
monkeypox
Featured
Recommendations
22
New Publications
28
Language
Document type
No document type
40
Guidelines
37
Studies & Reports
31
Fact sheets
18
Situation Updates
16
Resource Platforms
10
Online Courses
8
Strategic & Response Plan
7
Training Material
5
Infographics
5
Videos
3
Manuals
1
Countries / Regions
Congo, Democratic Republic of
28
Nigeria
10
Africa
10
Global
6
Central African Republic
5
Latin America and the Carribbean
4
Germany
4
East and Southern Africa
4
Liberia
4
Mozambique
3
West and Central Africa
3
Ukraine
2
Togo
2
Western and Central Europe
2
Angola
2
Lesotho
1
Ghana
1
Sierra Leone
1
Cameroon
1
Zimbabwe
1
United Kingdom
1
South Africa
1
Brazil
1
Namibia
1
Mali
1
Chad
1
India
1
Authors & Publishers
Publication Years
Category
MPOX - Monkeypox
49
Guidelines
13
Studies & Reports
13
Policies
11
Humanitarian Crisis
8
Statistics
5
Communicable Diseases
3
Disaster Preparedness
3
Immunization
3
Online Courses & Platforms
2
COVID-19
2
Infection Control & Prevention (IPC)
2
Quality Control & Assurance
2
x MEDBOX Issue Brief & Annual Reports x
1
Monitoring & Evaluation
1
Emergency Care
1
IEC Material
1
Virology
1
Mobile Training Tools & Apps
1
Hemorrhagic Fever
1
Drugs & Medical Equipment
1
Community Health
1
General Guidelines
1
Disease Prevention & Control
1
Toolboxes
MPOX - Monkeypox
61
MPOX - Monkeypox
43
MPOX -Monkeybox Prevention & Control
27
Situation Reports, others
4
Public Health
3
Country specific documents
3
Infectious Diseases
3
IPC
2
Surveillance
2
Health Promotion
2
Biodiversity shift
2
Situation Reports & Updates
2
Drugs
1
HIV support organizations
1
Vaccines & Immunization
1
Key Resources
1
Plague
1
Influenza
1
Training
1
Ebola & Marburg
1
African Region
1
Standard Precautions
1
e-Learning
1
Discrimination & Stigma
1
Treatment Guidelines
1
Risk Communication & Community Engagement
1
Infection Control & Prevention (IPC)
1
Access & Strategy
1
Immunization Guidelines
1
COVAX Initiative
1
Others
1
Online Courses
1
Planetary Health
1
Falsified & Substandard
1
General documents One Health
1
Zoonoses
1
Appeals & Response Plans
1
Health Financing Toolbox
1
Zika
1
Assessment
1
Other Resources
1
Lobby and Advocacy
1
Chikungunya
1
Action Plans, Policies & Response
1
Meningitis & Encephalitis
1
Universal Health Coverage & Primary Health Care
1
Capacity Building
1
WHO Annual Meeting with Pharmaceutical Companies and Stakeholders
08 March 2016, Geneva
2015-06-03 - Board presentation - v32.pptx
January - December 2017
This report describes findings from a telephone survey with 1,316 people conducted in February 2021. The survey examined how people respond to public health and social measures (PHSMs) to prevent COVID-19. The sample is representative of households with access to a landline or cell phone, but does n...
Infectious diseases cause over one billion human infections per year, with millions of deaths each year globally. Extensive health and financial burden is seen from both established and emerging infectious diseases. Infectious diseases also affect plants and animals, which may pose threats to agricu...
As the nation’s public health leader, the Centers for Disease Control and Prevention (CDC) is actively engaged in a national effort to protect the public’s health from the harmful effects of climate change. Scientists from CDC’s National Center for Emerging and Zoonotic Infectious Diseases (NC...
Transmission-based precautions for the prevention and control of infections: aide-memoire
recommended
Transmission-based precautions (TBP) are used in addition to standard precautions for patients with known
or suspected infection or colonization1 with transmissible and/or epidemiologically significant pathogens.
The type of transmission-based precautions assigned to a patient depends on the trans...
The World Health Organization Regional Office for Africa (WHO AFRO), in accordance with recommendations from various WHO committees, has developed three flagship programmes to support Member States in the African region to prepare for, detect and respond to public health emergencies. They are the re...
WHO Ghana 2022 annual report
recommended
“2022 was an eventful year for the WHO Country Office in Ghana,” says Dr Francis Kasolo, WHO Representative to Ghana.
In 2022, WHO Ghana collaborated with partners to deliver interventions in support of the Government of Ghana's health sector agenda to ensure healthy lives for all towards ach...
CEPI is seeking to raise $3.5 billion to implement CEPI’s next 5-year plan. To mitigate the immediate threat of COVID-19 variants, it is activating key elements of this plan now—and seeking to mobilise a portion of this $3.5 billion in 2021. We have already launched R&D programmes to initiate de...
Smallpox eradication was certified in 1980. Mpox has been endemic in Central and West African countries since it was first detected in 1958 . It is a zoonosis; cases are often found close to tropical rainforests where various animals carry the orthopoxvirus that causes the disease. In endemic countr...
A erradicação da varíola humana (mpox em inglês) foi certificada em 1980. A varíola símia (mpox em inglês) é endêmica nos países da África Central e Ocidental desde a sua primeira detecção, em 1958. Trata-se de uma zoonose cujos casos geralmente ocorrem perto de florestas tropicais, ond...
El 23 de julio del 2022, el Director General de la OMS declaró el brote de viruela símica una emergencia de salud pública de importancia internacional. A raíz de esa declaración, se puso en marcha un dispositivo de respuesta coordinada con el objeto de interrumpir la transmisión y proteger a l...
On 13 August 2024, Africa Centres for Disease Control and Prevention (Africa CDC) declared the ongoing Mpox outbreak a Public Health Emergency of Continental Security (PHECS). This was followed the next day by the World Health Organization (WHO), which extended the alert internationally as a public ...
i. A person who is a contact of a probable or confirmed mpox case in the 21 days before the onset of signs or symptoms, and who presents with any of the following: acute onset of fever (>38.5°C), headache, myalgia (muscle pain/body aches), back pain, profound weakness or fatigue.
OR
ii. A per...
